57012-20-1

Basic information

• Product Name: (1,3-DIMETHYL-1H-PYRAZOL-5-YL)METHANOL
• Synonyms: BUTTPARK 93\11-63;(1,3-DIMETHYL-1H-PYRAZOL-5-YL)METHANOL;1,3-DIMETHYL-5-(HYDROXYMETHYL)PYRAZOLE;AKOS PAO-0016;RARECHEM AL BD 1315;5-(Hydroxymethyl)-1,3-dimethyl-1H-pyrazole;1,3-Dimethyl-5-(hydroxymethyl)-1H-pyrazole;(1,3-Dimethyl-1H-pyrazol-5-yl)methanol ,97%
• CAS NO: 57012-20-1
• Molecular Formula: C₆H₁₀N₂O
• Molecular Weight: 126.16
• Mol File: 57012-20-1.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 117-118°C 0,8mm
• Flash Point: 104.1 °C
• Appearance: /
• Density: 1.13 g/cm³
• Vapor Pressure: 0.0127mmHg at 25°C
• Refractive Index: 1.543
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 14.37±0.10(Predicted)
• CAS DataBase Reference: (1,3-DIMETHYL-1H-PYRAZOL-5-YL)METHANOL(CAS DataBase Reference)
• NIST Chemistry Reference: (1,3-DIMETHYL-1H-PYRAZOL-5-YL)METHANOL(57012-20-1)
• EPA Substance Registry System: (1,3-DIMETHYL-1H-PYRAZOL-5-YL)METHANOL(57012-20-1)

Safety Data

• Hazard Codes: Xi,Xn
• Statements: 36/37/38-22
• Safety Statements: 26-36/37/39
• Hazardous Substances Data: 57012-20-1(Hazardous Substances Data)

Usage

Chemical Properties

Light yellow solid

InChI:InChI=1/C6H10N2O/c1-5-3-6(4-9)8(2)7-5/h3,9H,4H2,1-2H3

Upstream product

• 5744-40-1 ethyl 1,3-dimethylpyrazole-5-carboxylate 
• 891273-63-5 1,3-dimethylpyrazole-5-carboxylic acid isopropyl ester 
• 10250-59-6 1,3-dimethyl-1H-pyrazole-5-carboxylic acid methyl ester 

Downstream Products

• 25016-09-5 1,3-dimethyl-1H-pyrazole-5-carbaldehyde 
• 873191-23-2 5-(bromomethyl)-1,3-dimethyl-1H-pyrazole 
• 1126776-55-3 4-{1-[(1,3-dimethyl-1H-pyrazol-5-yl)methyl]-3,5-dimethyl-1H-pyrazol-4-yl}benzonitrile 
• 1146853-33-9 1,3-dimethyl-5-[(4-nitrophenoxy)methyl]-1H-pyrazole 
• 1356998-41-8 (4-iodo-1,3-dimethyl-1H-pyrazol-5-yl)methanol 
• 1374868-77-5 (4-bromo-1,3-dimethyl-1H-pyrazol-5-yl)methanol 

Relevant articles and documents

MACROCYCLIC COMPOUNDS

Disclosed are macrocyclic compounds of formula (I) comprising a 2-carboxy indole ring. Such compounds, and their pharmaceutically acceptable salts, are useful as Mcl-1 (myeloid cell leukemia-1) inhibitors. The compounds may be used in treating a disease o

SUBSTITUTED SULFONIC ACID AMIDE COMPOUNDS

The present invention relates to the use of substituted sulfonic acid amide compounds of formula I, wherein Ra, n, Het, A, Y and D are as defined in the claims and the N-oxides and the salts thereof for combating phytopathogenic harmful fungi,

FUSED PYRIMIDINE DERIVATIVES AND COMPOSITIONS THEREOF AS CXCR3 RECEPTOR MODULATORS, USEFUL IN PREVENTION AND TREATMENT OF INFLAMMATORY AND IMMUNOREGULATORY DISORDERS AND DISEASES

Compounds are provided having the formula: wherein variables Ra, R1, R2, R3, R4, A1, A4, L, Q, X and subscript n as described herein. The subject compounds are useful for treatment of inflammatory and immune conditions and diseases. Compositions and methods of treatment using the subject compounds are also provided. For example, the subject methods are useful for treatment of inflammatory and immune disorders and disease such as multiple sclerosis, rheumatoid arthritis, psoriasis, and inflammatory bowel disease.